J Gordon Millichap
Abstract
Open-access reader
The efficacy of topiramate in the treatment of idiopathic intracranial hypertension (IIH) was compared to acetazolamide in an open-label study of 40 patients (age range 16-50, median 32 years; male/female ratio 5/35) at Ege University Medical School, Izmir, Turkey.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The efficacy of topiramate in the treatment of idiopathic intracranial hypertension (IIH) was compared to acetazolamide in an open-label study of 40 patients (age range 16-50, median 32 years; male/female ratio 5/35) at Ege University Medical School, Izmir, Turkey.
Key concepts: Topiramate, Acetazolamide, Medicine, Pediatrics, Pseudotumor cerebri, Anesthesia, Intracranial pressure, Psychiatry